A 3-Month, Multicenter, Double-Masked, Randomized, Parallel, Vehicle-Controlled Study of the Efficacy and Safety of 0.2% Brimonidine-Purite Opthalmic Solution for the Treatment of Acute Non-Arteritic Anterior Ischemic Optic Neuropathy